Effect of incretin-based therapies on cancers of digestive system among 101 595 patients with type 2 diabetes mellitus: a systematic review and network meta-analysis combining 84 trials with a median duration of 30 weeks

OBJECTIVES: To evaluate the risk of cancers of digestive system with incretin-based therapies among patients with type 2 diabetes mellitus. RESEARCH DESIGN AND METHODS: Medline, Embase, Cochrane Library and ClinicalTrials.gov databases were searched for randomized controlled clinical trials that com...

Descripción completa

Detalles Bibliográficos
Autores principales: Chai, Sanbao, Yu, Shuqing, Yang, Zhirong, Wu, Shanshan, Gao, Le, Wang, Haining, Zhang, Yuan, Zhan, Siyan, Ji, Linong, Sun, Feng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2019
Materias:
Metabolism
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6777405/
https://www.ncbi.nlm.nih.gov/pubmed/31641525
http://dx.doi.org/10.1136/bmjdrc-2019-000728

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6777405/
https://www.ncbi.nlm.nih.gov/pubmed/31641525
http://dx.doi.org/10.1136/bmjdrc-2019-000728

Ejemplares similares